Skip to main content

Advertisement

SpringerLink
Log in

Ficus benghalensis promotes the glucose uptake- Evidence with in silico and in vitro

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Background

Ficus benghalensis L. is traditionally used to manage diabetes; also used in various herbal formulations, and is indicated as an insulin sensitizer. Hence, present work attempted in identifying the probable lead hits to promote glucose uptake via computational approach followed by experimental evaluation of hydroalcoholic extract of Ficus benghalensis L. bark in yeast cells.

Methods

The in vitro assay for glucose uptake was performed in the baker yeast whereas in-silico study involved retrieving the phytoconstituents from open sources, and predicting for probable targets of diabetes followed by drug-likeness score, probable side effects, and ADMET profile. Homology modeling was performed to construct the target protein glucose transporter-2. In addition, the binding affinity of each ligand with glucose transporter was predicted using AutoDock 4.2.

Results

A total of 17 phytoconstituents from F. benghalensis were identified to possess the anti-diabetic effects. Among them, 4-methoxybenzoic acid scored the highest drug-likeness score and lupeol acetate had the maximum binding affinity of -8.02 kcal/mol with 9 pi-interactions via Tyr324, Phe323, Ile319, Ile200, Ile28, Phe24, and Ala451. Similarly, the extract showed the highest glucose uptake efficacy in yeast cells at 500 µg/mL.

Conclusion

Herein the present study reflected the probable activity of the phytoconstituents from F. benghalensis in promoting the glucose uptake via the in silico and in vitro approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4:
Fig. 5

Similar content being viewed by others

Abbreviations

3D:

3 Dimensional

ADMET:

Absorption, distribution, metabolism, and excretion

ChEBI:

Chemical Entities of Biological Interest

DM:

Diabetes Mellitus

PDB:

Protein data bank

RCSB:

Research Collaboratory for Structural Bioinformatics

SMILES:

Simplified molecular-input line-entry system

References

  1. LeRoith D. β-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. Am J Med. 2002;113(6):3–11.

    Article  Google Scholar 

  2. Ternikar SG, Patil MB, Pasha I, Dwivedi PSR. Gene ontology enrichment analysis of PPAR-γ modulators from Cassia glauca in diabetes mellitus. J Diabetes Metab Disord. 2021;20(2):1239–46.

    Article  CAS  Google Scholar 

  3. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008;88(11):1254–64.

    Article  Google Scholar 

  4. Vargas E, Podder V, Carrillo Sepulveda MA. Physiology, Glucose Transporter Type 4. [Updated 2021 May 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537322/

  5. Navale AM, Paranjape AN. Glucose transporters: physiological and pathological roles. Biophys Rev. 2016;8(1):5–9.

    Article  CAS  Google Scholar 

  6. El Bacha T, Luz M, Da Poian A. Dynamic Adaptation of Nutrient Utilization in Humans. Nat Educ. 2010;3(9):8.

    Google Scholar 

  7. Chadt A, Al-Hasani H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflugers Arch. 2020;472(9):1273–98.

    Article  CAS  Google Scholar 

  8. Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013;34(2–3):121–38.

    Article  CAS  Google Scholar 

  9. Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med. 2013;10(5):210–29.

    PubMed  PubMed Central  Google Scholar 

  10. Dwivedi PSR, Rasal VP. Identification of PTPN1B inhibitors from Momordica charantia and their enrichment analysis. J Phytopharmacol. 2020;9(1):38–45.

    Article  CAS  Google Scholar 

  11. Dwivedi PS, Patil R, Khanal P, Gurav NS, Murade VD, Hase DP, Kalaskar MG, Ayyanar M, Chikhale RV, Gurav SS. Exploring the therapeutic mechanisms of Cassia glauca in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics. RSC Adv. 2021;11(62):39362–75.

    Article  CAS  Google Scholar 

  12. Duyu T, Khatib NA, Khanal P, Patil BM, Hullatti KK. Network pharmacology-based prediction and experimental validation of Mimosa pudica for Alzheimer’s disease. J Phytopharmacol. 2020;9(1):46–53.

    Article  CAS  Google Scholar 

  13. Khanal P, Patil BM. Consolidation of network and experimental pharmacology to divulge the antidiabetic action of Ficus benghalensis L. bark. 3 Biotech. 2021;11(5):238.

  14. Khanal P, Patil BM. In vitro and in silico anti-oxidant, cytotoxicity and biological activities of Ficus benghalensis and Duranta repens. Chin Herb Med. 2020;12(4):406–13.

    Article  Google Scholar 

  15. Khanal P, Patil BM. Reversal of insulin resistance by Ficus benghalensis bark in fructose-induced insulin-resistant rats. J Ethnopharmacol. 2022;284:114761.

    Article  CAS  Google Scholar 

  16. Khanal P, Patil BM. Gene set enrichment analysis of alpha-glucosidase inhibitors from Ficus benghalensis. Asian Pac J Trop Biomed. 2019;9(6):263–70.

    Article  CAS  Google Scholar 

  17. Khanal P, Patil BM. Integration of in silico, in vitro and ex vivo pharmacology to decode the anti-diabetic action of Ficus benghalensis L. bark. J Diabetes Metab Disord. 2020;19(2):1325–37.

  18. Dwivedi PSR, Patil VS, Khanal P, Bhandare VV, Gurav S, Harish DR, Patil BM, Roy S. System biology-based investigation of Silymarin to trace hepatoprotective effect. Comput Biol Med. 2022;142:105223.

  19. Dwivedi PSR, Khanal P, Gaonkar VP, Rasal VP, Patil BM. Identification of PTP1B regulators from Cymbopogon citratus and its enrichment analysis for diabetes mellitus. In Silico Pharmacol. 2021;9:30.

    Article  Google Scholar 

  20. Dwivedi PSR, Rasal VP, Kotharkar E, Khanal P. Gene set enrichment analysis of PPAR-γ regulators from Murraya odorata Blanco. J Diabetes Metab Disord. 2021;20(1):369–75.

    Article  CAS  Google Scholar 

  21. Roy A, Dement AD, Cho KH, Kim JH. Assessing glucose uptake through the yeast hexose transporter 1 (Hxt1). PLoS One. 2015;10(3):e0121985.

  22. Singh V, Bedi GK, Shri R. In vitro and In vivo antidiabetic evaluation of selected culinary-medicinal mushrooms (Agaricomycetes). Int J Med Mushrooms. 2017;19(1):17–25.

    Article  Google Scholar 

  23. Rehman G, Hamayun M, Iqbal A, Ul Islam S, Arshad S, Zaman K, Ahmad A, Shehzad A, Hussain A, Lee I. In Vitro Antidiabetic Effects and Antioxidant Potential of Cassia nemophila Pods. Biomed Res Int. 2018;2018:1824790.

    Article  Google Scholar 

  24. Cos P, Vlietinck AJ, Berghe DV, Maes L. Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-ofconcept.’ J Ethnopharmacol. 2006;106(3):290–302.

    Article  CAS  Google Scholar 

  25. Degtyarenko K, De Matos P, Ennis M, Hastings J, Zbinden M, McNaught A, Alcántara R, Darsow M, Guedj M, Ashburner M. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 2007;36(s1):D344–50.

    Article  Google Scholar 

  26. MolSoft molecules in silico. Drug-Likeness and molecular property prediction. Available at: https://molsoft.com/mprop/

  27. Ivanov SM, Lagunin AA, Rudik AV, Filimonov DA, Poroikov VV. ADVERPred–Web service for prediction of adverse effects of drugs. J Chem Inf Model. 2018;58(1):8–11.

    Article  CAS  Google Scholar 

  28. Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z, Li W, Liu G, Tang Y. admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics. 2019;35(6):1067–9.

  29. Cirillo VP. Mechanism of glucose transport across the yeast cell membrane. J Bacteriol. 1962;84(3):485–91.

    Article  CAS  Google Scholar 

  30. Halgren TA. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 1996;17(5-6):490–519.

  31. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26(2):283–91.

    Article  CAS  Google Scholar 

  32. Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA. Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract. 2011;93(S1):S52–9.

    Article  CAS  Google Scholar 

  33. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32(S1):S62–7.

    Article  Google Scholar 

  34. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martín C. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020;21(17):6275.

    Article  CAS  Google Scholar 

  35. Vallon V, Sharma K. Sodium-glucose transport: role in diabetes mellitus and potential clinical implications. Curr Opin Nephrol Hypertens. 2010;19(5):425–31.

    Article  CAS  Google Scholar 

  36. Sharma H, Chandola HM. Prameha in Ayurveda: correlation with obesity, metabolic syndrome, and diabetes mellitus. Part 1-etiology, classification, and pathogenesis. J Altern Complement Med. 2011;17(6):491–6.

  37. Sørensen SS, Christensen F, Clausen T. The relationship between the transport of glucose and cations across cell membranes in isolated tissues. X. Effect of glucose transport stimuli on the efflux of isotopically labelled calcium and 3-O-methylglucose from soleus muscles and epididymal fat pads of the rat. Biochim Biophys Acta. 1980;602(2):433–45.

  38. Calado J, Santer R, Rueff J. Effect of kidney disease on glucose handling (including genetic defects). Kidney Int Suppl. 2011;120:S7-13.

    Article  CAS  Google Scholar 

  39. Santer R, Schneppenheim R, Suter D, Schaub J, Steinmann B. Fanconi-Bickel syndrome–the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur J Pediatr. 1998;157(10):783–97.

    Article  CAS  Google Scholar 

  40. Thorens B. GLUT2, glucose sensing and glucose homeostasis. Diabetologia. 2015;58(2):221–32.

    Article  CAS  Google Scholar 

  41. Berger C, Zdzieblo D. Glucose transporters in pancreatic islets. Pflugers Arch. 2020;472(9):1249–72.

    Article  CAS  Google Scholar 

  42. Reddy KP, Singh A, et al. Synthesis of novel triterpenoid (lupeol) derivatives and their in vivo antihyperglycemic and antidyslipidemic activity. Bioorganic Med Chem Lett. 2009;19(15):4463–6.

    Article  Google Scholar 

  43. Kottireddy S, Koora S. Lupeol exerts its antidiabetic activity through insulin receptor and glucose transporter-4 in gracilis muscle in high fat and sucrose-induced diabetic rats. Drug Invent Today. 2019;11(9):2258–64.

    Google Scholar 

  44. Shreenithi S, Vishnupriya V, Ponnulakshmi R, Gayathri R, Madhan K, Shyamaladevi B, Selvaraj J. In silico and in vivo approach to identify the antidiabetic activity of lupeol. Drug Invent Today. 2019;11(5):1113–6.

    Google Scholar 

  45. Oyinloye BE, Adekiya TA, Aruleba RT, Ojo OA, Ajiboye BO. Structure-Based Docking Studies of GLUT4 towards Exploring Selected Phytochemicals from Solanum xanthocarpum as a Therapeutic Target for the Treatment of Cancer. Curr Drug Discov Technol. 2019;16(4):406–16.

    Article  CAS  Google Scholar 

  46. Cersosimo E, Triplitt C, Solis-Herrera C, et al. Pathogenesis of Type 2 Diabetes Mellitus. [Updated 2018 Feb 27]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279115/

Download references

Acknowledgements

The authors are thankful to Principal KLE College of Pharmacy Belagavi, KLE Academy of Higher Education and Research (KAHER) Belagavi.

Funding

This work has not received any funds from any national or international agencies in any financial or non-financial means to declare.

Author information

Author notes

  1. Vaishnavi Shankar Madiwalar and Prarambh S. R. Dwivedi contributed equally.

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, KLE College of Pharmacy Belagavai, KLE Academy of Higher Education and Research (KAHER), Belagavi, 590010, India

    Vaishnavi Shankar Madiwalar, Prarambh S. R. Dwivedi, Ashwini Patil, Soham M. N. Gaonkar, Vrunda J. Kumbhar, Pukar Khanal & B. M. Patil

Authors
  1. Vaishnavi Shankar Madiwalar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prarambh S. R. Dwivedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashwini Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Soham M. N. Gaonkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vrunda J. Kumbhar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pukar Khanal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. M. Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Pukar Khanal or B. M. Patil.

Ethics declarations

Conflict of interest

All the authors of this manuscript declare that they do not have any conflict of interest in any financial means. All the authors have read and approved this manuscript.

Ethical statement

This work does not include any animal or human participation.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Madiwalar, V.S., Dwivedi, P.S.R., Patil, A. et al. Ficus benghalensis promotes the glucose uptake- Evidence with in silico and in vitro. J Diabetes Metab Disord 21, 429–438 (2022). https://doi.org/10.1007/s40200-022-00989-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-022-00989-2

Keywords

Search

Navigation